By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Can-Fite BioPharma Ltd. 

Reinhold Cohn House
P.O.Box: 4060
Tel Aviv      Israel
Phone: 03-7109330 Fax: 03-5606405


Drug Discovery

Company News
Can-Fite BioPharma (CFBI) Issued Japanese Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/5/2014 10:37:04 AM
Can-Fite BioPharma (CFBI) To Present At Rodman & Renshaw Global Investment Conference In New York City On September 9, 2014 9/3/2014 4:31:40 PM
Can-Fite BioPharma (CFBI) Reports First Six Months 2014 Results 9/3/2014 3:40:47 PM
New Data Shows High Efficacy For Can-Fite BioPharma (CFBI)'s CF101 In Rheumatoid Arthritis And Psoriasis Patients 8/6/2014 7:16:01 AM
Can-Fite BioPharma (CFBI) CEO To Deliver Scientific Presentation And Serve On Expert Panel At Purines 2014 In Bonn, Germany On July 23-27, 2014 7/21/2014 1:29:41 PM
Can-Fite BioPharma (CFBI)'s CF102 Approved For Compassionate Use In Israel For Liver Cancer Patient 7/10/2014 10:03:32 AM
Can-Fite BioPharma (CFBI) To Exhibit At Biotechnology Industry Organization (BIO) International Convention In San Diego On June 23 - 26, 2014 6/19/2014 7:34:27 AM
Grifols Completes Patient Enrollment In Its Phase2/3 Psoriasis Trial; Final Results Are Expected In Q1 2015 6/17/2014 10:50:26 AM
Can-Fite BioPharma (CFBI) To Participate In Newport Coast Securities Conference In New York & ROTH Conference In London 6/10/2014 6:22:33 AM
Can-Fite BioPharma (CFBI) Announces That The FDA Has Agreed With Its Phase 2 Liver Cancer Protocol 6/2/2014 9:30:30 AM